Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors

Although mutational inactivation of p53 is found in 50% of all human tumors, a subset of tumors display defective p53 function, but retain wild-type (WT) p53. Here, direct and indirect mechanisms leading to the loss of WT p53 activities are discussed. We summarize the oncogenic roles of iASPP, an in...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Dong, Peixin, Ihira, Kei, Hamada, Junichi, Watari, Hidemichi, Yamada, Takahiro, Hosaka, Masayoshi, Hanley, Sharon J.B., Kudo, Masataka, Sakuragi, Noriaki
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2015
Teme:
Review
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4652980/
https://ncbi.nlm.nih.gov/pubmed/26343523
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items